Seroepidemiology of the recent mumps virus outbreaks in Ireland

Journal of Clinical Virology

Volumn 53, Issue 4, 2012, Pages 320-324

  Hassan, Jaythoon ^a   Dean, Jonathan ^a   Moss, Eibhlín ^a   Carr, Michael J ^a   Hall, William W ^a   Connell, Jeff ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

Gender bias; Mumps outbreaks; Mumps virus specific IgM; Susceptibility to infection

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADOLESCENT; ADULT; ARTICLE; CHILD; COHORT ANALYSIS; DISEASE SEVERITY; FEMALE; GENDER BIAS; HUMAN; IMMUNE RESPONSE; INFANT; IRELAND; MAJOR CLINICAL STUDY; MALE; MUMPS; MUMPS VIRUS; NONHUMAN; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; SEROEPIDEMIOLOGY; SEROLOGY; SEX DIFFERENCE;

ACUTE DISEASE; ADOLESCENT; ADULT; AGE DISTRIBUTION; ANTIBODIES, VIRAL; ANTIBODY SPECIFICITY; CHILD; CHILD, PRESCHOOL; DISEASE OUTBREAKS; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INFANT; IRELAND; MALE; MUMPS; MUMPS VIRUS; SEROEPIDEMIOLOGIC STUDIES; SEX DISTRIBUTION; YOUNG ADULT;

EID: 84858148642     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2011.12.022     Document Type: Article

References (30)

1. Gee S, O'Flanagan D, Fitzgerald M, Cotter S. Mumps in Ireland, 2004-2008. Euro Surveill 13, pii=18857.
2. Health Protection Surveillance Centre. Annual report 2005. Mumps in Ireland, 2004-2005, p. 79-83.
3. Health Protection Surveillance Centre. Annual report 2009. Vaccine preventable diseases. 1. Mumps; 2009, p. 20-21.
4. Di Renzi M., Jackson S., Gee S., Cotter S. Increase in mumps in Ireland in late. Euro Surveill 2004, 8. pii=2608.
5. Department of Health and Human Services Healthy people 2010: understanding and improving health 2000 November, Government Printing Office, Washington, DC, [accessed 17.03.08]. http://www.healthypeople.gov/document/html/objectives/14-01.htm, 2nd ed.
6. Dayan G.H., Quinlisk M.P., Parker A.A., Barskey A.E., Harris M.L., Hill Schwartz J.M., et al. Recent resurgence of mumps in the United States. N Engl J Med 2008, 358:1580-1589.
7. Vandermeulen C., Leroux-Roels G., Hoppenbrouwers K. Mumps outbreaks in highly vaccinated populations. Human Vaccines 2009, 5:494-496.
8. Perry K.R., Brown D.W.G., Parry J.V., Panday S., Pipkin C., Richards A. Detection of measles, mumps and rubella antibodies in saliva using antibody capture radioimmunoassay. J Med Virol 1993, 40:235-240.
9. Reid F., Hassan J., Irwin F., Waters A., Hall W., Connell J. Epidemiologic and diagnostic evaluation of a recent mumps outbreak using oral fluid samples. J Clin Virol 2008, 41:134-137.
10. Carr M.J., Moss A., Waters A., Dean J., Jin L., Coughlan S., et al. Molecular epidemiological evaluation of the recent resurgence in mumps virus infections in Ireland. J Clin Microbiol 2010, 48:3288-3294.
11. CDC Brief report: mumps activity - United States, January 1-October 7, 2006. MMWR 2006;55:1152-3.
12. Watson-Creed G., Saunders A., Scott J., Lowe L., Pettipas J., Hachette T.F. Two successive outbreaks of mumps in Nova Scotia among vaccinated adolescents and young adults. Can Med Assoc J 2006, 175:483-488.
13. Whelan J., van Binnendlijk R., Greenland K., Fanoy E., Khargi M., Yap K., et al. Ongoing mumps outbreak in a student population with high vaccination coverage, Netherlands, 2010. Euro Surveill 2010, 15. pii=19554.
14. Kuzmanovska G., Polozhani A., Mikik V., Stavridis K., Aleksoskl B., Cvetanovska Z., et al. Mumps outbreak in the former Yugoslav Republic of Macedonia, January 2008-June 2009: epidemiology and control measures. Euro Surveill 2010, 15. pii=19586.
15. Barskey A.E., Glasser J.W., LeBaron C.W. Mumps resurgence in the United States: a historical perspective on unexpected elements. Vaccine 2009, 27:6186-6195.
16. Kanra G., Isik P., Kara A., Cengiz A.B., Seçmeer G., Ceyhan M. Complementary findings in clinical and epidemiologic features of mumps and mumps meningoencephalitis in children without mumps vaccination. Pediatr Int 2004, 46:663-668.
17. Koskiniemi M., Donner M., Pettay O. Clinical appearance and outcome in mumps encephalitis in children. Acta Paediatr Scand 1983, 72:603-609.
18. Leboreiro-Fernandez A., Moura-Ribeiro M.V., Leboreiro I.E., Sawan F.M., Ventura A.R., Barbosa K.C. Mumps meningoencephalitis. An epidemiological approach. Arq Neuropsiquiatr 1997, 55:12-15.
19. Otto W., Mankertz A., Santibanez S., Saygili H., Wenzel J., Jilg W., et al. Ongoing outbreak of mumps affecting adolescents and young adults in Bavaria, Germany, August to October 2010. Euro Surveill 2011, 15. pii=19748.
20. Casimir G.J., Mulier S., Hanssens L., Zylberberg K., Duchateau J. Gender differences in inflammatory markers in children. Shock 2010, 33:258-262.
21. Invernizzi P., Pasini S., Selmi C., Gershwin M.E., Podda M. Female predominance and X chromosome defects in autoimmune diseases. J Autoimmun 2009, 33:12-16.
22. Ovsyannikova I.G., Jacobson R.M., Dhiman N., Vierkant R.A., Pankratz V.S., Poland G.A. Human leukocyte antigen and cytokine receptor gene polymorphisms associated with heterogeneous immune responses to mumps viral vaccine. Pediatrics 2008, 121:e1091-e1099.
23. Green M.S., Shohat T., Lerman Y., Cohen D., Slepon R., Duvdevani P., et al. Sex differences in the humoral antibody response to live measles vaccine in young adults. Int J Epidemiol 1994, 23:1078-1081.
24. Mitchell L.A., Zhang T., Tingle A.J. Differential antibody responses to rubella virus infection in males and females. J Infect Dis 1992, 166:1258-1265.
25. Ovsyannikova I.G., Jacobson R.M., Vierkant R.A., Pankratz V.S., Poland G.A. HLA supertypes and immune responses to measles-mumps-rubella viral vaccine: findings and implications for vaccine design. Vaccine 2007, 25:3090-3100.
26. Poland G.A., Ovsyannikova I.G., Jacobson R.M. Personalized vaccines: the emerging field of vaccinomics. Expert Opin Biol Ther 2008, 8:1659-1667.
27. Senanayake S.N. Mumps: a resurgent disease with protean manifestations. Med J Aust 2008, 189:456-459.
28. Hilleman M.R. Past, present and future of measles, mumps and rubella virus vaccines. Pediatrics 1992, 90:149-153.
29. Kutty P.K., Kruszon-Moran D.M., Dayan G.H., Alexander J.P., Williams N.J., Garcia P.E., et al. Seroprevalence to antibody to mumps virus in the US population, 1999-2004. J Infect Dis 2010, 202:667-674.
30. Murray H., Corcoran B. 73% MMR uptake for HSE schools mumps campaign. Epi-Insight 2009, 10(6).